{{Rsnum
|rsid=1926657
|Gene=ABCC4
|Chromosome=13
|position=95222702
|Orientation=plus
|GMAF=0.2567
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCC4
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 68.1 | 30.1 | 1.8
| HCB | 40.9 | 44.5 | 14.6
| JPT | 43.4 | 44.2 | 12.4
| YRI | 38.8 | 49.7 | 11.6
| ASW | 52.6 | 43.9 | 3.5
| CHB | 40.9 | 44.5 | 14.6
| CHD | 46.3 | 46.3 | 7.4
| GIH | 51.5 | 40.6 | 7.9
| LWK | 50.0 | 41.8 | 8.2
| MEX | 60.3 | 36.2 | 3.4
| MKK | 41.7 | 42.3 | 16.0
| TSI | 68.6 | 28.4 | 2.9
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs1926657
|PubMedID=17903305
|Condition=Breast cancer
|Gene=ABCC4
|Risk Allele=
|pValue=2.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1926657
|Name_s=
|Gene_s=ABCC4
|Feature=
|Evidence=PubMed ID:17903305; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study (Initial Sample Size: 1,345 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Breast cancer.
|Drugs=
|Drug Classes=
|Diseases=Breast Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356381
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1926657
|overall_frequency_n=98
|overall_frequency_d=128
|overall_frequency=0.765625
|n_genomes=54
|n_genomes_annotated=0
|n_haplomes=83
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}